In addition, the positive association between cyclin D1 expression and tumor progression has been validated in different cancers, including lung adenocarcinoma, head and neck squamous cell carcinoma, and esophageal squamous cell carcinoma (ESCC) (51–53). This evidence concerns the gene CCND1 and cancer.